Skip to main content
main-content

01.12.2014 | Methodology | Ausgabe 1/2014 Open Access

The Journal of Headache and Pain 1/2014

Revised French guidelines for the diagnosis and management of migraine in adults and children

Zeitschrift:
The Journal of Headache and Pain > Ausgabe 1/2014
Autoren:
Michel Lanteri-Minet, Dominique Valade, Gilles Geraud, Christian Lucas, Anne Donnet
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1129-2377-15-2) contains supplementary material, which is available to authorized users.

Competing interests

MLM declares conflicts of interest with: Allergan, Almirall SAS, AstraZeneca Pharmaceuticals, GlaxoSmithKline Inc, Grunenthal, Eli Lilly & Company, Johnson & Johnson, Medtronic, Menarini, Merck, Pierre Fabre, Pfizer Inc, Sanofi-Aventis, UCB, Zambon.
DV declares conflicts of interest with: Allergan, Almirall, BMS, MSD, GSK, Janssen Cilag, Menarini, MSD, Pfizer, Sanofi-Aventis, UCB, Astra-Zeneca, Zambon.
GG declares conflicts of interest with: Allergan, AstraZeneca Pharmaceuticals, Menarini, Merck, Pfizer Inc., Zambon.
CL declares conflicts of interest with: Allergan, Almirall, AstraZeneca Pharmaceuticals, Boehringer, GlaxoSmithKline Inc, Grunenthal, Lilly, Menarini, Merck, SanofiAventis, Pfizer Inc., UCB-Schwarz-Pharma, Zambon.
AD declares conflicts of interest with: Allergan, Almirall SAS, AstraZeneca Pharmaceuticals, GlaxoSmithKline Inc, Grunenthal, Merck, Menarini, Orkyn, Pfizer Inc, Zambon.

Authors’ contributions

MLM, DV, GG, CL and AD drafted the manuscript. All authors read and approved the final manuscript.

Without Abstract

Zusatzmaterial
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2014

The Journal of Headache and Pain 1/2014 Zur Ausgabe

Neu im Fachgebiet AINS

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise